Chemomab Therapeutics Ltd.

Ownership Transactions Reported by 12 Insiders

Symbol
CMMB on Nasdaq
Location
Kiryat Atidim, Building 7, Tel Aviv, Israel

There are no Buy or Sell transactions made by insiders since 11/5/2023

Chemomab Therapeutics Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
OrbiMed Israel GP Ltd. 10%+ Owner $10.1M Jan 3, 2023
Adi Mor Chief Scientific Officer, Director $2.86M Jan 3, 2023
Neil Cohen Director $50.3K Mar 16, 2023
Sigal Fatal Chief Financial Officer $26.2K Jun 14, 2023
Dale R. Pfost Chief Executive Officer, Director $12.6K Mar 14, 2022
Donald Marvin Executive VP, CFO & COO $10.1K Mar 16, 2022
Joel Michael Maryles Director $7.2K May 24, 2022
Nissim Darvish Director $6.03K Jun 14, 2023
Matthew B. Frankel Chief Medical Officer Nov 14, 2022
Alan Moses Director Mar 16, 2023
Claude Nicaise Director Mar 16, 2023
Jill M. Quigley Director Jun 16, 2023

Recent Insider Transactions by Companies or Individuals for Chemomab Therapeutics Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.